The Computed Tomography Market, estimated at USD 9.07 Bn in 2025, is expected to exhibit a CAGR of 6.5% and reach USD 14.09 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on adoption of growth strategies such as launch of new products, and this is expected to drive the global computed tomography market growth . For instance, on May 17, 2025, Koninklijke Philips N.V., a global medical technology company, announced the launch of the Philips CT 3500, a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programs. Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing features that help to deliver the consistency, speed, and first-time-right image quality needed for confident diagnoses by clinicians.
Global Computed Tomography Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. The virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of things from one place to another.
During the COVID-19 pandemic, healthcare services used various diagnostic ways for analyzing patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among which, a chest CT scan is used for lungs to check for infected parts, and this is expected to drive growth of the global computed tomography market over the forecast period. For instance, in June 2025, a study published in The National Center for Biotechnology Information (NCBI) concluded that the features for computed tomography for COVID-19 include consolidation in lung periphery and bilateral Ground-glass opacity (GGO) with pattern.